P2.30. Assessing the Impact of Using Disease-Specific Novel Value Elements on Cost-Effectiveness Results in Lung Cancer - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Yong Yuan
Meta Tag
Speaker Yong Yuan
Topic Global Health, Health Services & Health Economics: Health Economics
impact assessment
disease-specific novel value elements
cost-effectiveness results
lung cancer
cost-effectiveness analyses
clinical trial outcomes
healthcare costs
metastatic non-small cell lung cancer
literature review
cost-effectiveness model
Powered By